Seminars in Hematology
Volume 43, Supplement 3 , Pages S23-S27, April 2006

Consideration in Hemophilia Therapy Selection

  • Steven Pipe

      Affiliations

    • Corresponding Author InformationAddress correspondence to Steven Pipe, MD, Pediatric Medical Director, Hemophilia and Coagulation Disorders Program, University of Michigan, Room L2110 Women’s Hospital, 1500 E Medical Center Dr, Ann Arbor, MI 48109.

Hemophilia and Coagulation Disorders Program, University of Michigan, Ann Arbor, MI.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0037-1963(06)00026-6

doi:10.1053/j.seminhematol.2006.02.002

Seminars in Hematology
Volume 43, Supplement 3 , Pages S23-S27, April 2006

Article Tools